March 20–22, 2023 | Basel, Switzerland,
March 28–30, 2023 | Digital
Reconnecting and Facilitating Global Partnerships
Meet your next strategic partner at Europe's largest springtime partnering event.
WAYS TO ATTEND
Join as a general attendee to digitally meet one-to-one with your peers and access event content all via our partnering platform, partneringONE®.
PRESENT YOUR COMPANY
We want to hear all about your company’s latest innovations! Get the attention you deserve from real decision makers.
SPONSOR & EXHIBIT
Position your company among the innovators of the life science industry through a sponsorship package that will improve your visibility with prospective partners through digital and in-person solutions.
Countless opportunities to engage with global life science partners
Access thousands of industry leaders in one place and find your potential partners with the world’s leading web-based system, partneringONE.
Whether you are on early-stage projects, an innovative startup, an established biotech or a midsized pharma company, we provide the platform to get noticed by true decision makers.
Hear the latest industry trends from key biotech and pharma leaders, during our workshops and panels. Ask questions and gain empowering knowledge that will help you plan for your business.
Stay tuned for the 2023 Agenda
Our bustling exhibit hall offers a wide range of services, innovative solutions and many more opportunities to explore the full potential that the industry has to offer.
This year we are back face-to-face! Leave no stone unturned through the numerous partnering meetings, program sessions, lunch, exhibit receptions and of course all the evening activities we have planned for you.
BIO-Europe Spring “live” was one of the most important events of the year in the Biotechnological world. The organizers were able to convert it to a "virtual" meeting keeping the same qualities, with the added convenience of using a very well-designed partnering and conferencing system for remote participation. A definitive must-attend congress.